Clinical Trial Update: Assessing Pyridium for Post-Sling Urinary Retention [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Pyridium for post-sling urinary retention with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Retention

Drugs mentioned

• Pyridium® (phenazopyridine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Urinary Retention | Phase 4 | Status: COMPLETED | Results posted: 2019-10-29